TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis

Published:2016-08 Issue: Volume:305 Page:194-202
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Lin Chao-Feng,Huang Han-Li,Peng Chieh-Yu,Lee Yu-Ching,Wang Hui-Po,Teng Che-Ming,Pan Shiow-Lin

Funder

Taipei Medical University-Shuang Ho Hospital

National Science Council of Taiwan

Ministry of Science and Technology of Taiwan

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference39 articles.

1. Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury;Adhikari;Curr. Atheroscler. Rep.,2006

2. Cell cycle progression: new therapeutic target for vascular proliferative disease;Braun-Dullaeus;Circulation,1998

3. Nuclear factor-κB activity and arterial response to balloon injury;Cercek;Atherosclerosis,1997

4. Pyrimidinoceptor potentiation of macrophage PGE2 release involved in the induction of nitric oxide synthase;Chen;Br. J. Pharmacol.,2000

5. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction;Chomczynski;Anal. Biochem.,1987

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mulberry polyphenols ameliorate atherogenic migration and proliferation by degradation of K-Ras and downregulation of its signals in vascular smooth muscle cell;International Journal of Medical Sciences;2022

2. Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202”;Toxicology and Applied Pharmacology;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3